1,517
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines

, , &
Pages 2927-2935 | Received 06 Oct 2015, Accepted 17 Nov 2015, Published online: 15 Dec 2015

Figures & data

Figure 1. Reaction scheme for the synthesis of SNA. 1st step: synthesis of an alginate-glutathione conjugate. 2nd step: nitrosation of alginate-glutathione conjugate.

Figure 1. Reaction scheme for the synthesis of SNA. 1st step: synthesis of an alginate-glutathione conjugate. 2nd step: nitrosation of alginate-glutathione conjugate.

Table 1. Amount of glutathione (SH groups) determined by Ellman’s test (precursor of SNA F1).

Table 2. Amount of glutathione (SH groups) determined by Ellman’s test (precursor of SNA F2).

Table 3. Amount of nitrites determined by the Griess and Saville tests.

Figure 2. Stability of SNA F1

SNA F2
in the Ussing chamber without rat intestine at 37 °C (n = 3, mean ± SD).

Figure 2. Stability of SNA F1 Display full size SNA F2 Display full size in the Ussing chamber without rat intestine at 37 °C (n = 3, mean ± SD).

Figure 3. Stability of SNA F2 at different pH conditions at 4 °C in dark pH 1.2

pH 7.0
and pH 8.4
(n = 3, mean ± SD).

Figure 3. Stability of SNA F2 at different pH conditions at 4 °C in dark pH 1.2 Display full size pH 7.0 Display full size and pH 8.4 Display full size (n = 3, mean ± SD).

Figure 4. Concentrations of GSNO

NO2/NO
and NO3 (
) as the percentage of the initial concentration of the donor chamber (100 μM). Donor chamber; (n = 3, mean value ± SD).

Figure 4. Concentrations of GSNO Display full size NO2/NO Display full size and NO3 (Display full size) as the percentage of the initial concentration of the donor chamber (100 μM). Donor chamber; (n = 3, mean value ± SD).

Figure 5. Concentrations of GSNO

NO2/NO
and NO3
as the percentage of the initial concentration of the donor chamber (100 μM). Acceptor chamber; (n = 3, mean value ± SD).

Figure 5. Concentrations of GSNO Display full size NO2/NO Display full size and NO3 Display full size as the percentage of the initial concentration of the donor chamber (100 μM). Acceptor chamber; (n = 3, mean value ± SD).

Figure 6. Concentrations of SNA F2

NO2/NO
and NO3
as the percentage of the initial concentration of the donor chamber (100 μM). Donor chamber; (n = 3, mean value ± SD).

Figure 6. Concentrations of SNA F2 Display full size NO2/NO Display full size and NO3 Display full size as the percentage of the initial concentration of the donor chamber (100 μM). Donor chamber; (n = 3, mean value ± SD).

Figure 7. Concentrations of SNA F2

NO2/NO
and NO3
as the percentage of the initial concentration of the donor chamber (100 μM). Acceptor chamber; (n = 3, mean value ± SD).

Figure 7. Concentrations of SNA F2 Display full size NO2/NO Display full size and NO3 Display full size as the percentage of the initial concentration of the donor chamber (100 μM). Acceptor chamber; (n = 3, mean value ± SD).

Figure 8. Cell viability of Caco2 cell line after exposure to different concentrations of alginate, alginate-GSH conjugate and SNA F2 (n = 3, mean ± SD). For SNA F2, the concentrations are expressed in μM of NO; for the other polymers, corresponding concentration are used. *Kruskal–Wallis test (comparison with alginate): p < 0.05.

Figure 8. Cell viability of Caco2 cell line after exposure to different concentrations of alginate, alginate-GSH conjugate and SNA F2 (n = 3, mean ± SD). For SNA F2, the concentrations are expressed in μM of NO; for the other polymers, corresponding concentration are used. *Kruskal–Wallis test (comparison with alginate): p < 0.05.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.